P Wallace

2.0k total citations
16 papers, 1.8k citations indexed

About

P Wallace is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, P Wallace has authored 16 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in P Wallace's work include Nitric Oxide and Endothelin Effects (8 papers), Pain Mechanisms and Treatments (6 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). P Wallace is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Pain Mechanisms and Treatments (6 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). P Wallace collaborates with scholars based in United Kingdom, Mexico and United States. P Wallace's co-authors include Stephen L. Hart, R.C. Babbedge, Philip K. Moore, Z. Gaffen, Ademola O. Oluyomi, Peter K. Moore, A Gibson, Ian McFadzean, C. Wayman and Rachel Handy and has published in prestigious journals such as Trends in Pharmacological Sciences, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

P Wallace

16 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Wallace United Kingdom 13 1.2k 643 476 268 262 16 1.8k
R.C. Babbedge United Kingdom 11 1.4k 1.1× 688 1.1× 383 0.8× 231 0.9× 301 1.1× 12 1.8k
J Duhault France 21 542 0.4× 347 0.5× 455 1.0× 178 0.7× 374 1.4× 67 1.5k
Z. Gaffen United Kingdom 10 815 0.7× 393 0.6× 226 0.5× 167 0.6× 213 0.8× 11 1.1k
E. B. Nielsen Denmark 8 767 0.6× 426 0.7× 528 1.1× 259 1.0× 139 0.5× 10 1.4k
Seitaro Ohkuma Japan 26 574 0.5× 1.2k 1.9× 1.0k 2.1× 118 0.4× 120 0.5× 150 2.2k
R Boulu France 23 721 0.6× 867 1.3× 568 1.2× 104 0.4× 190 0.7× 73 2.0k
Stanley Kalsner Canada 25 671 0.5× 820 1.3× 917 1.9× 543 2.0× 72 0.3× 96 2.2k
R. Sercombe France 25 408 0.3× 564 0.9× 484 1.0× 137 0.5× 135 0.5× 73 2.0k
Suzanne Doolen United States 18 485 0.4× 720 1.1× 627 1.3× 94 0.4× 366 1.4× 27 1.6k
Philip Bland‐Ward United Kingdom 10 609 0.5× 322 0.5× 211 0.4× 126 0.5× 219 0.8× 17 941

Countries citing papers authored by P Wallace

Since Specialization
Citations

This map shows the geographic impact of P Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Wallace more than expected).

Fields of papers citing papers by P Wallace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Wallace. The network helps show where P Wallace may publish in the future.

Co-authorship network of co-authors of P Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of P Wallace. A scholar is included among the top collaborators of P Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Wallace. P Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wallace, P, et al.. (2002). The Rho kinase inhibitor, Y-27632, inhibits contractile responses to carbachol, thapsigargin and potassium in the mouse anococcygeus. British Journal of Pharmacology. 137. 1 indexed citations
2.
Wallace, P, et al.. (1999). Thapsigargin-induced tone and capacitative calcium influx in mouse anococcygeus smooth muscle cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 360(4). 368–375. 23 indexed citations
3.
Wayman, C., P Wallace, Alan Gibson, & Ian McFadzean. (1999). Correlation between store-operated cation current and capacitative Ca2+ influx in smooth muscle cells from mouse anococcygeus. European Journal of Pharmacology. 376(3). 325–329. 27 indexed citations
4.
Gibson, A, Ian McFadzean, P Wallace, & C. Wayman. (1998). Discussion. Trends in Pharmacological Sciences. 19(7). 266–269. 141 indexed citations
5.
Handy, Rachel, P Wallace, & Philip K. Moore. (1996). Inhibition of nitric oxide synthase by isothioureas: Cardiovascular and antinociceptive effects. Pharmacology Biochemistry and Behavior. 55(2). 179–184. 13 indexed citations
6.
Handy, Rachel, et al.. (1996). Inhibition of nitric oxide synthase by 1‐(2‐trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects. British Journal of Pharmacology. 119(2). 423–431. 73 indexed citations
7.
Handy, Rachel, P Wallace, Z. Gaffen, Kevin J. Whitehead, & Philip K. Moore. (1995). The antinociceptive effect of 1‐(2‐trifluoromethylphenyl) imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. British Journal of Pharmacology. 116(5). 2349–2350. 83 indexed citations
8.
Wallace, P, et al.. (1994). Effect of 7‐nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase. British Journal of Pharmacology. 113(1). 282–288. 19 indexed citations
9.
Moore, Philip K., P Wallace, Z. Gaffen, Stephen L. Hart, & R.C. Babbedge. (1993). Characterization of the novel nitric oxide synthase inhibitor 7‐nitro indazole and related indazoles: antinociceptive and cardiovascular effects. British Journal of Pharmacology. 110(1). 219–224. 410 indexed citations
10.
Moore, Peter K., R.C. Babbedge, P Wallace, Z. Gaffen, & Stephen L. Hart. (1993). 7‐Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti‐nociceptive activity in the mouse without increasing blood pressure. British Journal of Pharmacology. 108(2). 296–297. 375 indexed citations
11.
Gibson, A, R.C. Babbedge, Sandra R. Brave, et al.. (1992). An investigation of some S‐nitrosothiols, and of hydroxy‐arginine, on the mouse anococcygeus. British Journal of Pharmacology. 107(3). 715–721. 64 indexed citations
12.
Babbedge, R.C., et al.. (1992). Synergistic anti‐nociceptive effect ofl‐NG‐nitro arginine methyl ester (l‐NAME) and flurbiprofen in the mouse. British Journal of Pharmacology. 106(2). 493–497. 30 indexed citations
13.
Moore, Philip K., Ademola O. Oluyomi, R.C. Babbedge, P Wallace, & Stephen L. Hart. (1991). l‐NG‐nitro arginine methyl ester exhibits antinociceptive activity in the mouse. British Journal of Pharmacology. 102(1). 198–202. 423 indexed citations
14.
Hart, Stephen L., Ademola O. Oluyomi, P Wallace, R.C. Babbedge, & Philip K. Moore. (1990). L-NG-nitra arginine (L-NOARG), a selective inhibitor of nitric oxide biosynthesis exhibits anti-nociceptive activity in the mouse. European Journal of Pharmacology. 183(4). 1440–1441. 4 indexed citations
15.
Gibson, Alan, P Wallace, & Howard A. Bern. (1986). Cardiovascular effects of urotensin II in anesthetized and pithed rats. General and Comparative Endocrinology. 64(3). 435–439. 64 indexed citations
16.
Wallace, P, et al.. (1976). The effect of drugs on various parameters of mouse behaviour in a modified head-dipping test [proceedings].. PubMed Central. 57(3). 474P–474P. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026